A. Platz

发表

Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.

L. Kanter, J. Hansson, U. Ringborg, 2003, Journal of the National Cancer Institute.

A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF.

M. Lindström, K. Wiman, C. Asker, 2002, Cancer letters.

Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes.

M. Heinzelmann, A. Platz, H. Polk, 1999, Annals of surgery.

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.

M. Inganäs, J. Hansson, U. Ringborg, 1997, Journal of the National Cancer Institute.

Heparin binding protein (CAP37) differentially modulates endotoxin-induced cytokine production.

M. Heinzelmann, A. Platz, W. Cheadle, 2001, International journal of surgical investigation.

Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.

N. Hayward, J. Hansson, A. Platz, 2004, Human pathology.

Novel O6‐methylguanine‐DNA methyltransferase SNPs: A frequency comparison of patients with familial melanoma and healthy individuals in Sweden

S. Ma, S. Egyházi, J. Hansson, 2002, Human mutation.

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing

J. Lundeberg, J. Hansson, Esther Edlundh-Rose, 2006, Melanoma research.

Biallelic Deletions in INK4 in Cutaneous Melanoma Are Common and Associated with Decreased Survival

S. Egyházi, J. Hansson, U. Ringborg, 2005, Clinical Cancer Research.

p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin

U. Ringborg, A. Platz, B. Ragnarsson-Olding, 2004, Melanoma research.

Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families

Å. Borg, H. Olsson, C. Ingvar, 2001, Genes, chromosomes & cancer.

Hereditary cutaneous melanoma.

J. Hansson, U. Ringborg, A. Platz, 2000, Seminars in cancer biology.

N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.

U. Ringborg, A. Platz, B. Ragnarsson-Olding, 1998, The Journal of investigative dermatology.

Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases.

T. Norberg, U. Ringborg, A. Platz, 1996, British Journal of Cancer.

Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations

U. Ringborg, A. Platz, B. Lagerlöf, 1994, Melanoma research.

Chromosomal localization of human glutathione transferase genes of classes alpha, mu and pi

B. Mannervik, A. Platz, G. Levan, 1989, Human Genetics.

Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic‐based population study

J. Hansson, U. Ringborg, A. Platz, 1998 .

Transthyretin messenger ribonucleic acid expression in the pancreas and in endocrine tumors of the pancreas and gut.

V. P. Collins, A. Platz, A. Carlström, 1990, The Journal of clinical endocrinology and metabolism.

Endocytosis of heparin-binding protein (CAP37) is essential for the enhancement of lipopolysaccharide-induced TNF-alpha production in human monocytes.

M. Heinzelmann, A. Platz, H. Polk, 1999, Journal of immunology.

Heparin Binding Protein (CAP37) is an Opsonin for Staphylococcus aureus and Increases Phagocytosis in Monocytes

M. Heinzelmann, A. Platz, F. N. Miller, 1998, Inflammation.

Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma.

M. Inganäs, U. Ringborg, A. Platz, 1996, British Journal of Cancer.

Lipopolysaccharide-Induced TNF-( CAP 37 ) Is Essential for the Enhancement of Endocytosis of Heparin-Binding Protein

M. Heinzelmann, A. Platz, H. Polk, 1999 .

Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study.

J. Hansson, U. Ringborg, A. Platz, 1998, International journal of cancer.

Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma

C. Larsson, B. Teh, G. Robertson, 2000, International journal of cancer.

Mutationally altered ribonucleotide reductase from Escherichia coli: characterization of mutations isolated on multicopy plasmids

B. Sjöberg, A. Platz, Britt-Marie Sjobergt, 1984, Journal of bacteriology.

Analyses of phagocytosis, evoked oxidative burst, and killing of black yeasts by human neutrophils: a tool for estimating their pathogenicity?

S. Jentsch, A. Platz, S. de Hoog, 2003, Medical mycology.

Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.

L. Kanter, J. Hansson, U. Ringborg, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site

J. Hansson, U. Ringborg, A. Platz, 2008, Molecular oncology.

Analysis of O6-methylguanine-DNA methyltransferase mRNA in fine needle biopsies from human melanoma metastases by reverse transcription and polymerase chain reaction.

J. Hansson, A. Platz, E. Tani, 1996, European journal of cancer.

Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes

U. Ringborg, A. Platz, B. Ragnarsson-Olding, 2002, Melanoma research.

Geographical variation in the penetrance of CDKN2A mutations for melanoma.

Florence Demenais, Johan Hansson, Paola Ghiorzo, 2002, Journal of the National Cancer Institute.

Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis.

P. Guldberg, J. Zeuthen, A. Platz, 1998, Nucleic acids research.

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

L. Kanter, J. Hansson, U. Ringborg, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Construction and characterization of hybrid plasmids containing the Escherichia coli nrd region

B. Sjöberg, A. Platz, Britt-Marie Sjoberg, 1980, Journal of bacteriology.

Chemotherapy resistance mechanisms.

U. Ringborg, A. Platz, 1996, Acta oncologica.

[Role of laparoscopy in the management of acute appendicitis].

M. Heinzelmann, A. Platz, D. Gianom, 1999, Zentralblatt fur Chirurgie.

Enzymic modification of a tyrosine residue to a stable free radical in ribonucleotide reductase.

B. Sjöberg, A. Platz, P. Reichard, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma

Ann-Marie Wennberg, Johan Hansson, Birgitta Sander, 2004, Melanoma research.

Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients

N. Hayward, J. Hansson, A. Platz, 2004 .

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

J. Hansson, U. Ringborg, J. Hashemi, 2000, Cancer research.

Advances in Brief CDKN 2 A Germline Mutations in Individuals with Multiple Cutaneous Melanomas 1

J. Hansson, U. Ringborg, J. Hashemi, 2000 .

Pyrosequencing as an alternative to single-strand conformation polymorphism analysis for detection of N-ras mutations in human melanoma metastases.

Åsa Sivertsson, J. Lundeberg, J. Hansson, 2002, Clinical chemistry.

Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma

U. Ringborg, A. Platz, A. Höög, 1995, Melanoma research.

Cytoplasmic and nuclear accumulation of β‐catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma

J. Hansson, U. Ringborg, A. Platz, 2001, International journal of cancer.

Melanoma development in relation to non-functional p16/INK4A protein and dysplastic naevus syndrome in Swedish melanoma kindreds.

J. Hansson, J. Hashemi, A. Platz, 1999, Melanoma research.

Glutathione transferase P1-1 expression in human melanoma metastases: correlation to N-RAS mutations and expression.

B. Mannervik, U. Ringborg, A. Platz, 1995, Acta oncologica.

Early detection and prevention of cutaneous malignant melanoma: Emphasis on Swedish activities

U. Ringborg, A. Platz, M. Broberg, 1991, Medical oncology and tumor pharmacotherapy.

Alterations in intracellular deoxyribonucleotide levels of mutationally altered ribonucleotide reductases in Escherichia coli

B. Sjöberg, A. Platz, M. Karlsson, 1985, Journal of bacteriology.

Differences among human tumor cell lines in the expression of glutathione transferases and other glutathione-linked enzymes.

B. Mannervik, A. Platz, M. Widersten, 1990, Carcinogenesis.

Expression of class-pi glutathione transferase in drug-resistant human-melanoma cells

J. Hansson, B. Mannervik, U. Ringborg, 1987 .

The Ras farnesylation inhibitor BZA-5B increases the resistance to cisplatin in a human melanoma cell line.

J. Hansson, A. Platz, M. Shoshan, 1997, Anticancer research.